Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Analysis of α-synuclein seed amplification assay in carriers of GBA1 and LRRK2 pathogenic variants.
Journal: Journal of Parkinson's disease
Published: January 23, 2026
Radiological markers of CSF α-synuclein aggregation in Parkinson's disease patients.
Journal: NPJ Parkinson's disease
Published: March 21, 2024
Mild cognitive impairment among LRRK2 and GBA1 patients with Parkinson's disease.
Journal: Parkinsonism & related disorders
Published: September 22, 2023
Digital Mobility Measures: A Window into Real-World Severity and Progression of Parkinson's Disease.
Digital Mobility Measures: A Window into Real-World Severity and Progression of Parkinson's Disease.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: September 05, 2023
The Influence of GBA and LRRK2 on Mood Disorders in Parkinson's Disease.
Journal: Movement disorders clinical practice
Published: September 20, 2022
Glucocerebrosidase Activity Is Not Associated with Parkinson's Disease Risk or Severity.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: December 27, 2021
Prevalence of ten LRRK2 variants in Parkinson's disease: A comprehensive review.
Journal: Parkinsonism & related disorders
Published: December 21, 2021
Glucocerebrosidase Activity is not Associated with Parkinson's Disease Risk or Severity.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: May 30, 2021
Mutations in GBA and LRRK2 Are Not Associated with Increased Inflammatory Markers.
Journal: Journal of Parkinson's disease
Published: May 17, 2021
Detecting Sensitive Mobility Features for Parkinson's Disease Stages Via Machine Learning.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: February 03, 2021
Quantitative digital clock drawing test as a sensitive tool to detect subtle cognitive impairments in early stage Parkinson's disease.
Journal: Parkinsonism & related disorders
Published: January 22, 2021
Glucosylceramide in cerebrospinal fluid of patients with GBA-associated and idiopathic Parkinson's disease enrolled in PPMI.
Journal: NPJ Parkinson's disease
Published: January 14, 2021
Last Updated: 09/26/2026